Author: Wang, Shuncong; Mulier, Stefaan; Jonscher, Charles; Ye, Sheng; Chen, Lei; Feng, Yuanbo; Li, Yue; Ni, Yicheng
Title: Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19? Cord-id: 7yyo5drm Document date: 2020_10_20
ID: 7yyo5drm
Snippet: There are widespread anecdotal reports of seemingly successful treatment among the early (three to seven days from symptoms) stage coronavirus disease 2019 (COVID-19) patients with the drug hydroxychloroquine (HCQ), and randomized placebo-controlled trials of HCQ in outpatient settings are underway. In this note, we (1) report observational evidence and present scientific reasoning as to why early treatment with HCQ may succeed while treatment later in the disease progression is likely to fail a
Document: There are widespread anecdotal reports of seemingly successful treatment among the early (three to seven days from symptoms) stage coronavirus disease 2019 (COVID-19) patients with the drug hydroxychloroquine (HCQ), and randomized placebo-controlled trials of HCQ in outpatient settings are underway. In this note, we (1) report observational evidence and present scientific reasoning as to why early treatment with HCQ may succeed while treatment later in the disease progression is likely to fail and (2) hypothesize a public health regime under which HCQ may be used to mitigate the impact of the current pandemic.
Search related documents:
Co phrase search for related documents- absence evidence and long term treatment: 1
- additional need and long term treatment: 1, 2, 3, 4, 5
- additional need and lupus erythematosus: 1
- long term treatment and lupus erythematosus: 1, 2
- lupus erythematosus and lysosome ph: 1
Co phrase search for related documents, hyperlinks ordered by date